Mobile medical applications for melanoma risk assessment: False assurance or valuable tool?

Proceedings of the Annual Hawaii International Conference on System Sciences

Volumn , Issue , 2014, Pages 2675-2684

  Chadwick, Xavier ^a   Loescher, Lois J ^b   Janda, Monika ^c   Soyer, H Peter ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF ARIZONA   (United States)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMMERCE; GRADING; MEDICAL APPLICATIONS; ONCOLOGY; RISK ASSESSMENT; SYSTEMS SCIENCE;

HISTOPATHOLOGIC DIAGNOSIS; LESION ANALYSIS; MOBILE PLATFORM; RISK GRADE; RISK IDENTIFICATION; SKIN CANCERS; SKIN LESION;

DERMATOLOGY;

EID: 84902296804     PISSN: 15301605     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/HICSS.2014.337     Document Type: Conference Paper

References (33)

1. E. Gilmer, "Developing Mobile Apps as Medical Devices: Understanding U.S. Government Regulations. What Medical Mobile App Developers Need to Know," developerWorks, 2013, http://www.ibm.com/developerworks/mobile/ library/mo-fda-med-devices/index.html.
2. Therapeutic Goods Administration, "Australian Regulatory Guidelines for Medical Devices (ARGMD)," Vol. 1.1, Department of Health and Ageing, 2011, http://www.tga.gov.au/industry/devices-argmd.htm.
3. C. L. Foreman, "Health Information Technologies: Administration Perspectives on Innovation and Regulation," U. S. Food and Drug Administration, 2013, http://www.fda.gov/NewsEvents/Testimony/ucm344395.htm
4. U.S. Food and Drug Administration, "Draft Guidance for Industry and Food and Drug Administration Staff - Mobile Medical Applications," Silver Spring, MD, 2011, http://www.fda.gov/downloads/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/UCM263366.pdf
5. Australian Institute of Health and Welfare & Australasian Association of Cancer Registries 2012. "Cancer in Australia: An overview, 2012," Australian Institute of Health and Welfare: Canberra.
6. N. Howlander, A.M. Noone, M. Krapcho et al. "SEER Cancer Statistics Review, 1975-2010," 2013, National Cancer Institute: Bethesda, MD.
7. American Cancer Society, "Cancer Facts & Figures," Atlanta, 2013 http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-036845.pdf.
8. C. M. Balch, J. E. Gershenwald, S. J. Soong, et al, "Final Version of 2009 AJCC Melanoma Staging and Classification," Journal of Clinical Oncology, 2009, 27, 6199-6206.
9. D. S. Rigel, R. J. Friedman, A. W. Kopf, and D. Polsky, "ABCDE-An Evolving Concept in the Early Detection of Melanoma," Archives of Dermatology, 2005, 141, 1032-1034.
10. C. Massone, E.M. Wurm, and H.P. Soyer, "Teledermatology," Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa italiana di dermatologia e sifilografia, 2008, 143, 213-218.
11. J. A. Wolf, J. Moreau, O. Akilov, et al, "Diagnostic Inaccuracy of Smartphone Applications for Melanoma Detection," JAMA Dermatology, 2013, 2382, 1-4.
12. N. A. Ferrero, D. S. Morrell, and C. N. Burkhart, "Skin Scan: A Demonstration of the Need for FDA Regulation of Medical Apps on iPhone," Journal of the American Academy of Dermatology, 2013, 68, 515-516.
13. Y. Robson, S. Blackford, and D. Roberts, "Caution in Melanoma Risk Analysis with Smartphone Application Technology," The British Journal of Dermatology, 2012, 167, 703-704.
14. L. Pfaeffli, R. Maddison, R. Whittaker, et al, "A mHealth Cardiac Rehabilitation Exercise Intervention: Findings from Content Development Studies," BMC Cardiovascular Disorders, 2012, 12, 36-45.
15. C. Rabin and B. Bock, "Desired Features of Smartphone Applications Promoting Physical Activity," Telemedicine Journal & E-Health, 2011, 17, 801-803.
16. M. Shin, "Secure Remote Health Monitoring with Unreliable Mobile Devices," Journal of Biomedicine & Biotechnology, 2012, 1-5.
17. C-C. Yang and H.-C. Chang, "Selecting Representative Affective Dimensions Using Procrustes Analysis: An Application to Mobile Phone Design," Applied Ergonomics, 2012, 43, 1072-1080.
18. T. Zayas-Caban and B.E. Dixon, "Considerations for the Design of Safe and Effective Consumer Health IT Applications in the Home. Quality & Safety in Health Care," 2010, 19 (Suppl 3), 161-7.
19. Institute of Medicine, "Health IT and Patient Safety: Building Safer Systems for Better Care," Institute of Medicine of the National Academies: Washington DC, 2011.
20. G. Argenziano, H.P. Soyer, S. Chimenti, and R. Talamini., Dermoscopy of Pigmented Skin Lesions: Results of a Consensus Meeting via the Internet. Journal of the American Academy of Dermatology, 2003. 48, 679-93.
21. M. Shippen, "Dr Mole," (v1.0.5) [Android application], 2012, http://www.doctormole.com/.
22. Anonymous, "Skin Scan," v1.4, 2012, https://skinvision.com/? locale=en.
23. C. Munteanu and S. L. Cooclea, "SpotMole Plus," (v3.9) [Android Application], http://www.spotmole.com/.
24. H. D. Corporation, "MelApp," (vA1.0) [Android App], 2012, http://www.melapp.net/.
25. Anonymous. (2012). "Mole Detective"," (v. 2.53), 2012, http://moledetective.com/
26. M. Janda, L. J. Loescher, and H. P. Soyer, "Enhanced Skin Self-Examination - A Novel Approach to Skin Cancer Monitoring and Follow-Up," JAMA Dermatology, 2013, 149, 231-236
27. R. Moynihan, J. Doust, and D. Henry, "Preventing Overdiagnosis: How to Stop Harming the Healthy," British Medical Journal, 2012, 344, e3502.
28. P. R. Hull, N. G. Piemontesi, and J. Lichtenwald, "Compliance with Self-Examination Surveillance in Patients with Melanoma and Atypical Moles: An Anonymous Questionnaire Study," Journal of Cutaneous Medicine & Surgery, 2011, 15, 97-102.
29. R. Schiffner, J. Schiffner-Rohe, M. Landthaler, and W. Stolz, "Long-Term Dermoscopic Follow-up of Melanocytic Naevi: Clinical Outcome and Patient Compliance," British Journal of Dermatology, 2003, 149, 79-86.
30. J. F. Aitken, M. Janda, J. B. Lowe, M. et al., "Prevalence of Whole-Body Skin Self-Examination in a Population at High Risk for Skin Cancer (Australia)," Cancer Causes & Control, 2004, 15, 453-463.
31. P. Helsing and M. Loeb, "Small Diameter Melanoma: A Follow-Up of the Norwegian Melanoma Project," British Journal of Dermatology, 2004, 151, 1081-1083.
32. A. R. Rhodes, "Cutaneous Melanoma and Intervention Strategies to Reduce Tumor-Related Mortality: What We Know, What We Don't Know, and What We Think We Know That Isn't So," Dermatologic Therapy, 2006, 19, 50-69.
33. V. de Giorgi, I. Savarese, S. Rossari, A., et. al., "Features of Small Melanocytic Lesions: Does Small Mean Benign? A Clinical-Dermoscopic Study," Melanoma Research, 2012, 22, 252-56.